MedPath

The Effect of High-Calorie Formula on Nutritional and Clinical Outcomes Among Infants After Congenital Heart Surgery

Not Applicable
Completed
Conditions
Congenital Heart Disease in Children
Malnutrition, Child
Interventions
Dietary Supplement: High-calorie density formula (1 kcal/ml)
Dietary Supplement: Standard formula (0.67 kcal/ml)
Registration Number
NCT05945459
Lead Sponsor
National Cardiovascular Center Harapan Kita Hospital Indonesia
Brief Summary

The goal of this clinical trial is to compare the effect of high-calorie density formula (HDF) and standard formula (SF) in infants with congenital heart surgery. The main questions it aims to answer are:

1. Is there any difference in nutritional status between both groups after 3 months?

2. Is there any difference in calorie intake per day between both groups during hospitalization?

3. Is there any difference in clinical outcomes (mortality, duration of using mechanical ventilation, length of stay, and events of side effects) between both groups?

A group of participants will be given HDF (1 kcal/ml) from enrollment until three months. Researchers will compare them to the group of participants who are given SF (0.67 kcal/ml) to see if there is any difference in nutritional status, calorie intake, and other clinical outcomes between the two groups.

Detailed Description

The study is a randomized, double-blind controlled trial to compare the efficacy of HDF formula compared to SF in nutritional and clinical outcomes among infants who had congenital heart surgery in Harapan Kita National Cardiovascular Centre (HKNCC), Jakarta, Indonesia.

The researchers use consecutive sampling to include eligible infants and obtain informed consent from the parent or legal guardian of infants who fulfilled the eligibility criteria. Block randomization is done by a research assistant, and then the allocation is prepared using a sealed envelope to assign infants into HDF and SF groups.

Participants are then assessed by a multi-professional team and given enteral feeds based on local guidelines. Routine follow-up is done at 2 weeks, 1 month, 2 months, and 3 months after the intervention to record weight, length, and any episode of complication or adverse events.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
158
Inclusion Criteria
  • Patient of less than 1 year of age who underwent congenital heart surgery procedure in Harapan Kita National Cardiovascular Center
  • Risk adjustment for congenital heart surgery (RACHS) score 2-4
  • Patients who do not get exclusive breastfeeding due to any cause
Exclusion Criteria
  • History of prematurity (<37 weeks gestational age)
  • Formula intolerance or cow milk protein allergy
  • Lethal chromosome abnormality
  • Galactosemia
  • Gastrointestinal malformation or obstruction
  • Renal failure
  • Liver disease
  • Metabolic abnormalities
  • Need for extracorporeal membrane oxygenation

Drop-out

  • Patients who develop diarrhea for more than 5 days during the study period despite getting adequate therapy
  • Patients who need prolonged total parenteral nutrition (e.g., gastrointestinal bleeding due to any cause, chylothorax, etc.)
  • Patients with necrotizing enterocolitis during the study period

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention armHigh-calorie density formula (1 kcal/ml)High-calorie density formula (1 kcal/ml)
Control armStandard formula (0.67 kcal/ml)Standard formula (0.67 kcal/ml)
Primary Outcome Measures
NameTimeMethod
Nutritional statusAfter 3 months of intervention

Numeric data of weight-for-length z-score (WLZ), length-for-age z-score (LAZ) and weight-for-age z-score (WAZ) based on the 2006 World Health Organization (WHO) Child Growth Standard

Secondary Outcome Measures
NameTimeMethod
WeightAfter 1, 2, and 3 months of intervention

Numeric data of absolute weight (kg)

LengthAfter 1, 2, and 3 months of intervention

Numeric data of absolute length (cm)

Calorie intakeFrom the date of randomization to the date of discharge, assessed up to 3 months

Numeric data of the infants' total calorie intake (kcal/kg/day) during hospitalization

Malnutrition riskAfter 1, 2, and 3 months of intervention

Risk ratios of malnutrition, defined as weight-for-length \<-2 based on 2006 WHO Child Growth Standard

MortalityThrough study completion, an average of 3 months

The event proportion of mortality (%)

Weight-for-age z-score changesFrom the date of randomization to after 1, 2, and 3 months of intervention

Difference of weight-for-age z-score based on The 2006 WHO Child Growth Standard

Length-for-age z-score changesFrom the date of randomization to after 1, 2, and 3 months of intervention

Difference of length-for-age z-score based on The 2006 WHO Child Growth Standard

Weight-for-length z-score changesFrom the date of randomization to after 1, 2, and 3 months of intervention

Difference of weight-for-length z-score based on The 2006 WHO Child Growth Standard

Duration of mechanical ventilationFrom the date of randomization to the date of hospital discharge, assessed up to 3 months

The difference of mechanical ventilation duration (hours)

Length of stayFrom the date of randomization to the date of discharge, assessed up to 3 months

The difference of lengths of stay in intensive care unit and hospital (days)

Side effectsFrom the date of randomization to the date of hospital discharge, assessed up to 3 months

The event proportion (%) of vomiting, diarrhea, gastrointestinal bleeding, constipation, and \>50% residual gastric content

Trial Locations

Locations (1)

National Cardiovascular Center Harapan Kita

🇮🇩

Jakarta, Indonesia

© Copyright 2025. All Rights Reserved by MedPath